Double - blind comparison of <font color="red">doxepin_2</font> versus <font color="red">bupropion_2</font> in outpatients with a major depressive disorder . 
<br>
<br> A double - blind controlled study comparing the effects of <font color="red">bupropion_2</font> to <font color="red">doxepin_2</font> in outpatients with primary depression was conducted to evaluate efficacy and safety differences between the two drugs . Following a 7-day placebo washout period , patients could be treated for up to 13 weeks on either treatment . Antidepressant response was assessed by the Hamilton Depression and Anxiety Scales , Clinical Global Severity and Improvement Ratings , and the Zung Self - Rating Depression Scale . Comparable efficacy between the compounds was found across the 13-week study . <font color="red">Doxepin_2</font> differed from <font color="red">bupropion_2</font> mainly on the sleep factor of the Hamilton Depression Scale , with <font color="red">doxepin_2</font> improving sleep to a greater extent than <font color="red">bupropion_2</font> <font color="red">._2</font> <font color="red">Doxepin_2</font> produced a greater incidence of anticholinergic side effects , including dry mouth , constipation , sleepiness , and tiredness , in comparison to <font color="red">bupropion_2</font> <font color="red">._2</font> Also , increased appetite and weight gain were consistent side effects of <font color="red">doxepin_2</font> relative to <font color="red">bupropion_2</font> <font color="red">._2</font>